Xr Securities LLC Amarin Corp Plcuk Call Options Transaction History

Xr Securities LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 Apr 14, 2022	SELL	$2.85 - $3.73 $38,190 - $49,982	-13,400 Closed	0 $0
Q4 2021 Jan 10, 2022	BUY	$3.24 - $5.18 $43,416 - $69,412	13,400 New	13,400 $1,000
Q1 2021 Apr 29, 2021	SELL	$5.03 - $8.8 $57,845 - $101,200	-11,500 Closed	0 $0
Q4 2020 Jan 13, 2021	SELL	$4.04 - $5.31 $9,292 - $12,213	-2,300 Reduced 16.67%	11,500 $5,000
Q3 2020 Oct 28, 2020	BUY	$3.64 - $7.76 $50,232 - $107,088	13,800 New	13,800 $3,000
Q4 2018 Jan 03, 2019	SELL	$12.41 - $22.98 $251,923 - $466,494	-20,300 Closed	0 $0
Q3 2018 Oct 04, 2018	BUY	$2.45 - $16.27 $49,735 - $330,281	20,300 New	20,300 $108,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $222M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Xr Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Xr Securities LLC with notifications on news.